fotemustine has been researched along with Medulloblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baruchel, S; Bouffet, E; Gammon, J; Grant, RM; Hargrave, DR; Tariq, N | 1 |
| Boland, I; Gouyette, A; Lacroix, C; Lellouch-Tubiana, A; Margison, GP; Morizet, J; Parker, F; Pierre-Kahn, A; Poullain, MG; Terrier-Lacombe, MJ; Vassal, G; Vénuat, AM; Watson, AJ | 1 |
1 trial(s) available for fotemustine and Medulloblastoma
| Article | Year |
|---|---|
Phase I study of fotemustine in pediatric patients with refractory brain tumors.
Topics: Adolescent; Anemia; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Ependymoma; Female; Humans; Infant; Injections, Intravenous; Male; Medulloblastoma; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Sarcoma; Thrombocytopenia; Treatment Outcome | 2002 |
1 other study(ies) available for fotemustine and Medulloblastoma
| Article | Year |
|---|---|
Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; DNA Glycosylases; DNA Repair; Drug Screening Assays, Antitumor; Female; Glioma; Humans; Male; Medulloblastoma; Mice; Middle Aged; N-Glycosyl Hydrolases; Neoplasm Transplantation; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Organophosphorus Compounds; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |